Nduati James Ngoyo, Gatimu Samwel Maina, Kombe Yeri
School of Public Health, Jomo Kenyatta University of Science and Technology, Nairobi, Kenya.
Diabetic Foot Foundation of Kenya, Nairobi, Kenya.
East Afr Health Res J. 2022;6(2):196-202. doi: 10.24248/eahrj.v6i2.698. Epub 2022 Nov 30.
Screening for diabetic foot complications is often neglected, especially during routine and/or annual diabetes check-ups. We assessed the risk of diabetic foot complications among patients with type 2 diabetes in Kenya using the International Working Group on Diabetic Foot risk stratification guidelines to highlight the need for improved foot care.
We conducted a descriptive cross-sectional study in Mathari National Teaching and Referral Hospital in Kenya between July and October 2015. Seven hundred patients with type 2 diabetes were identified and 147 were systematically sampled. A trained podiatrist examined patients, and urine and blood samples were taken for biochemical tests and assessed by the investigating team.
In total, 44(29.9%) men and 103(70.1%) women were sampled; 75(51.0%) were aged over 55 years, 113(76.9%) were overweight/obese, 117(79.6%) had poor glycaemic control and 125(85%) had never had their feet screened for complications. Thirty participants (20.4%) were categorised as being at high risk for developing diabetic foot complications while 54(36.7%) had moderate risk, 53(36.1%) had low risk and 10(6.8%) had no risk. Compared to other risk groups, those with moderate risk for developing diabetic foot problems had higher mean levels of glycated haemoglobin (9.4%), albumin-creatinine ratio (50.3) and high-density lipoprotein cholesterol (1.4 mmol/L) at presentation. No other differences in clinical and laboratory profiles were noted.
Our results show high rates of obesity, and poor glycaemic control in patients with type 2 diabetes and 56.5% of patients are categorised as being a moderate-to-high risk for foot problems. This highlights the need for healthcare professionals and patients in Kenya to be sensitised regarding the importance of foot screening to prevent lower-extremity complications.
糖尿病足并发症的筛查常常被忽视,尤其是在常规和/或年度糖尿病检查期间。我们使用国际糖尿病足工作组风险分层指南评估了肯尼亚2型糖尿病患者发生糖尿病足并发症的风险,以强调改善足部护理的必要性。
2015年7月至10月,我们在肯尼亚马塔里国家教学和转诊医院进行了一项描述性横断面研究。确定了700例2型糖尿病患者,并系统抽取了147例。由一名经过培训的足病医生对患者进行检查,并采集尿液和血液样本进行生化检测,由研究团队进行评估。
共抽取了44名(29.9%)男性和103名(70.1%)女性;75名(51.0%)年龄超过55岁,113名(76.9%)超重/肥胖,117名(79.6%)血糖控制不佳,125名(85%)从未接受过足部并发症筛查。30名参与者(20.4%)被归类为发生糖尿病足并发症的高风险人群,54名(36.7%)为中度风险,53名(36.1%)为低风险,10名(6.8%)无风险。与其他风险组相比,发生糖尿病足问题中度风险的患者就诊时糖化血红蛋白平均水平较高(9.4%)、白蛋白-肌酐比值较高(50.3)和高密度脂蛋白胆固醇较高(1.4 mmol/L)。未发现临床和实验室特征的其他差异。
我们的结果显示2型糖尿病患者肥胖率高且血糖控制不佳,56.5%的患者被归类为足部问题的中高风险人群。这凸显了肯尼亚的医疗保健专业人员和患者需要提高对足部筛查以预防下肢并发症重要性的认识。